Randomized, two paralel groups, open clinical trial stratified by severity to stimate the cost-effectivity of surgical vs corticosteroid injection treatment on carpal tunnel syndrome

Federico Diaz González0 个研究点目标入组 70 人开始时间: 2013年5月20日最近更新: 2013年8月5日

适应症

试验速览

暂无简介。

•1.Informed consent
•2.Patients between 18 and 65 able to answer written questionnaires
•3.To satisfy one or more of the following symptoms: pain, paresthesias and / or hypoesthesia in the territory of the median nerve in hands
•4.Nerve conduction delay in the electromyogram (EMG)
•5.If the patient has bilateral clinically confirmed by EMG, the hand included will be choose by the patient
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 65
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 5

•1.Patients with Known thyroid disease, rheumatic diseases, diabetes, polyneuropathy, renal chronic failure or alcoholism.
•2.Patients who where treated previously with corticoid injection in the affected hand.
•3.Patients with any pathology in the affected limb of carpal tunnel syndrome (CTS)
•4.Patients with suggestive clinical cervicobraquialgias or nerve compression at any other levels.
•5.Presence of thenar atrophy or irreversible injury on the median nerve(nerve conduction absence measured by EMG)
•6.Contraindication to treatment with corticosteroids (Systemic fungal infection or hypersensitivity to corticosteroids or other components of the injection)
•7.Patients with any contraindication to surgery.
•8.Serious psychiatric condition.
•9.Evidence of uncontrolled concomitant serious illness.
•10.Pregnancy

发起方

Federico Diaz González